Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Caffeine for Acute Migraine Attack
NCT07022496Phase 4Recruiting
- Sponsor
- Ain Shams University
- Start
- Apr 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of caffeine in migraine, sponsored by Ain Shams University. Started Apr 2023; status: recruiting.
02
Drugs
caffeine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07022496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07022496.